Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results
Alzheimer's & Dementia · 2024
DOI: 10.1002/alz.13750 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Maurice Pasternak und 42 weiteren Autor:innen. Beteiligte Einrichtung: Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Frontotemporal Dementia, Magnetic Resonance Imaging, Cerebrovascular Circulation, C9orf72 Protein. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Weston Brain Institute, Medical Research Council UK.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Effective longitudinal biomarkers that track disease progression are needed to characterize the presymptomatic phase of genetic frontotemporal dementia (FTD). We investigate the utility of cerebral perfusion as one such biomarker in presymptomatic FTD mutation carriers. METHODS We investigated longitudinal profiles of cerebral perfusion using arterial spin labeling magnetic resonance imaging in 42 C9orf72 , 70 GRN , and 31 MAPT presymptomatic carriers and 158 non‐carrier controls. Linear mixed effects models assessed perfusion up to 5 years after baseline assessment. RESULTS Perfusion decline was evident in all three presymptomatic groups in global gray matter. Each group also featured its own regional pattern of hypoperfusion over time, with the left thalamus common to all groups. Frontal lobe regions featured lower perfusion in those who symptomatically converted versus asymptomatic carriers past their expected age of disease onset. DISCUSSION Cerebral perfusion is a potential biomarker for assessing genetic FTD and its genetic subgroups prior to symptom onset. Highlights Gray matter perfusion declines in at‐risk genetic frontotemporal dementia (FTD). Regional perfusion decline differs between at‐risk genetic FTD subgroups . Hypoperfusion in the left thalamus is common across all presymptomatic groups. Converters exhibit greater right frontal hypoperfusion than non‐converters past their expected conversion date. Cerebral hypoperfusion is a potential early biomarker of genetic FTD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
- Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
- Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, the Netherlands.
- Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.
- Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, Queen Square, London, UK.
ORCID-Profile: Maurice Pasternak
Förderung
- CIHR
- Weston Brain Institute
- Medical Research Council UK
- JPND GENFI-PROX
- Deutsche Forschungsgemeinschaft
- Munich Cluster for Systems Neurology
- MRC Clinician Scientist Fellowship
- NIHR Rare Disease Translational Research Collaboration
Zitieren
APA
Pasternak, M., Mirza, S. S., Luciw, N., Mutsaerts, H. J. M. M., Petr, J., Thomas, D., Cash, D., Bocchetta, M., Tartaglia, M. C., Mitchell, S. B., Black, S. E., Freedman, M., Tang-Wai, D., Rogaeva, E., Russell, L. L., Bouzigues, A., van Swieten, J. C., Jiskoot, L. C., Seelaar, H., …, & GENetic Frontotemporal dementia Initiative (GENFI) (2024). Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13750
Vancouver
Pasternak M, Mirza SS, Luciw N, Mutsaerts HJMM, Petr J, Thomas D, et al. Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results. Alzheimer's & Dementia. 2024. doi:10.1002/alz.13750
BibTeX
@article{Pasternak2024,
author = {Pasternak, Maurice and Mirza, Saira S and Luciw, Nicholas and Mutsaerts, Henri J M M and Petr, Jan and Thomas, David and Cash, David and Bocchetta, Martina and Tartaglia, Maria Carmela and Mitchell, Sara B and Black, Sandra E and Freedman, Morris and Tang-Wai, David and Rogaeva, Ekaterina and Russell, Lucy L and Bouzigues, Arabella and van Swieten, John C and Jiskoot, Lize C and Seelaar, Harro and Laforce, Robert and Tiraboschi, Pietro and Borroni, Barbara and Galimberti, Daniela and Rowe, James B and Graff, Caroline and Finger, Elizabeth and Sorbi, Sandro and de Mendonça, Alexandre and Butler, Chris and Gerhard, Alex and Sanchez-Valle, Raquel and Moreno, Fermin and Synofzik, Matthis and Vandenberghe, Rik and Ducharme, Simon and Levin, Johannes and Otto, Markus and Santana, Isabel and Strafella, Antonio P and MacIntosh, Bradley J and Rohrer, Jonathan D and Masellis, Mario and GENetic Frontotemporal dementia Initiative (GENFI), GENetic Frontotemporal dementia Initiative (GENFI)},
title = {Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results},
journal = {Alzheimer's & Dementia},
year = {2024},
doi = {10.1002/alz.13750}
}
EUVIMED